We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $59.29 · 17 analysts
Stored first · Google News · Yahoo Finance (English)
Centene stock reflects steady managed care positioning amid US healthcare policy shifts - Ad Hoc News
Centene stock reflects steady managed care positioning amid US healthcare policy shifts Ad Hoc News
Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating - marketscreener.com
Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating marketscreener.com
Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating
Wells Fargo Adjusts Price Target on Centene to $69 From $56, Maintains Equalweight Rating
Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks
Does Illinois Medicaid Renewal Solidify Centene’s Core Government Programs Franchise Narrative (CNC)? - simplywall.st
Does Illinois Medicaid Renewal Solidify Centene’s Core Government Programs Franchise Narrative (CNC)? simplywall.st
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 28. | After market close (AMC) | $1.05 | — | — | $47.45B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $2.63 | — | — | $42.49B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $5.69 | — | — | $109.21B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $4.32 | — | — | $72.31B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 27. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 23. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 05. 21. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2026. 05. 20. | Mizuho | — | Maintain | Neutral → Neutral | — | Mizuho: Neutral |
| 2026. 05. 20. | Deutsche Bank | — | Upgrade | Hold → Buy | — | Deutsche Bank: Hold → Buy |
| 2026. 05. 05. | TD Cowen | — | Maintain | Hold → Hold | — | TD Cowen: Hold |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.